Occudo Quantitative Strategies’s Procept Biorobotics PRCT Stock Holding History

Occudo Quantitative Strategies’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-8,671	Closed	-$698K	–	866
2024 Q4	$698K	Buy	8,671 +5,142	+146%	+$439K	0.13%	229
2024 Q3	$283K	Sell	3,529 -13,915	-80%	-$989K	0.05%	477
2024 Q2	$1.07M	Buy	17,444 +10,486	+151%	+$624K	0.19%	149
2024 Q1	$344K	Sell	6,958 -43,494	-86%	-$2.07M	0.06%	428
2023 Q4	$2.11M	Buy	50,452 +42,235	+514%	+$1.44M	0.29%	87
2023 Q3	$270K	Buy	+8,217	New	+$280K	0.03%	704
2023 Q1	–	Sell	-8,803	Closed	-$366K	–	1137
2022 Q4	$366K	Buy	+8,803	New	+$378K	0.04%	603

Other funds holding PRCT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Occudo Quantitative Strategies's PRCT Position: Q1 2025 in Review

Occudo Quantitative Strategies sold out of Procept Biorobotics (PRCT) in Q1 2025, closing a stake of 8,671 shares — an estimated $698K sold.

Occudo Quantitative Strategies first reported a position in PRCT in Q4 2022 and held it in 7 quarters. The position peaked at $2.11M in Q4 2023. 279 funds tracked by Wall St. Rank hold PRCT as of Q1 2025.

Occudo Quantitative Strategies reported no remaining Procept Biorobotics position as of Q1 2025 after selling out during the quarter.
Occudo Quantitative Strategies sold 8,671 Procept Biorobotics shares in Q1 2025, an estimated $698K.
Occudo Quantitative Strategies first reported a position in Procept Biorobotics in Q4 2022 and held it in 7 quarters.
Occudo Quantitative Strategies's Procept Biorobotics position peaked at $2.11M in Q4 2023.
279 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2025.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2025, filed 15 May 2025.